A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis.
| Image |  |
|---|---|
| Description | scientific article published on 26 May 2017 |
| Author/s |
author: Stefan Schönland Angela Dispenzieri Giampaolo Merlini Adam D Cohen Vishal Kukreti Raymond L Comenzo Giovanni Palladini Vaishali Sanchorawala Arnaud Jaccard |
| Publication date | May 26, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |